ACTRN12610000710022尚未招募4 期
An 8 week randomised, double-blind, placebo controlled trial investigating the role of adjunctive bioactive lipids specifically; docosahexaenoic acid (DHA) versus eicosapentaenoic acid (EPA) in Major Depressive Disorder - with a 6 week open label extension of DHA in patients aged 18-65years.
The Melbourne Clinic0 个研究点目标入组 90 人开始时间: 2010年8月26日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •diagnosis of major depressive episode
排除标准
- •other serious mental or neurological illness
研究者
相似试验
进行中（未招募）
2 期
The role of resveratrol in the management of metabolic dysregulations in non-alcoholic fatty liver disease: a randomised placebo controlled clinical trialnon-alcoholic fatty liver diseaseMetabolic and Endocrine - Metabolic disordersDiet and Nutrition - ObesityOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12612001135808Metro-South Queensland health20
尚未招募
3 期
Study the effect of herbal medicine, Sensoril (Aswagandha)in patients with chronic stressCTRI/2019/11/022100atreon Inc Branch Office India
已完成
不适用
A 8 week, randomized, double-blind, Placebo-controlled clinical trial of extracted Canavalia of complex for the for the for the evaluation of efficacy and safety on immune functioKCT0002757AEKYUNG Industry100
已完成
不适用
A 8 week, randomized, double-blind, Placebo-controlled clinical trial of RB-F for the evaluation of efficacy and safety on immune functioKCT0002646STR Biotech100
已完成
不适用
A 8 week, randomized, double-blind, Placebo-controlled clinical trial of CAEC(Canavalia gladiata Arctium lappa L.(root) Extract Complex) for the evaluation of efficacy and safety on immune functioKCT0003664AEKYUNG Industry100